Diabetes Complications
Panel of experts updates guidelines for use of KCI's V.A.C. diabetic foot therapy
Published in Obesity and Diabetes Week, July 31st, 2006
The new guidelines were published by a multidisciplinary panel of experts and are intended to update the findings presented in the 2004 guidelines from the Tucson Expert Consensus Conference (TECC) on V.A.C. therapy. The latest guidelines weigh the most current clinical evidence, refute or confirm current consensus, provide practical clinical guidance and best practices to clinicians treating diabetic foot wounds, and help to direct future research.
The updated guidelines...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes & Obesity
Calpain-10 polymorphisms contribute to diabetes risk by regulating abdominal obesity - Diabetes & Obesity
Novel cyanopyrrolidine analogues show diabetes and obesity therapy potential - Diabetes & Obesity
PPAR alpha improves pancreatic adaptation to insulin resistance and reduces lipotoxicity - Diabetes Epidemiology
Hepatic lipase gene variant impacts coronary heart disease risk differently in obese diabetics - Diabetes Therapy
alpha-Lipoic acid regulates AMP-activated protein kinase - Allergy & Immunology
beta cell autoimmunity linked to introduction age of fruits, berries and roots - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
